Edition: United Kingdom  
One News Page
“Probably the fastest-access news portal in the world”
Actelion News  |<  Page 1  >> 
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Sanofi and Johnson & Johnson May Battle for the Right to Overpay for Actelion

While attempting to offset biosimilar competition on their best-selling drugs, J&J and Sanofi could be making a big mistake by chasing Actelion.
Motley Fool

Top Actelion shareholder says backs J&J deal above 246 Sfr/share

LONDON (Reuters) - A top-30 investor in Swiss pharmaceutical company Actelion said he would back a takeover approach for the whole company from U.S. rival Johnson & Johnson above 246 Swiss francs.
Reuters

Videos for actelion

News video: Sanofi Said to Weigh Actelion Bid Challenging J&J

Sanofi Said to Weigh Actelion Bid Challenging J&J 04:21

Dec.06 -- Sanofi is reported to be considering a bid to challenge Johnson & Johnson's move to acquire Actelion Inc. Bloomberg's Ed Hammond has the details on "Bloomberg Markets."
Source: Bloomberg Global Business -

News video: Johnson & Johnson Looking To Absorb Actelion

Johnson & Johnson Looking To Absorb Actelion 00:37

Healthcare company Johnson and Johnson is eager to expand. According to Reuters the company recently upped its offer for Actelion, a swiss biotech group, in hopes of buying out the smaller company...
Source: Wochit Headline News -

News video: Johnson & Johnson Looking To Absorb Actelion

Johnson & Johnson Looking To Absorb Actelion 00:36

Healthcare company Johnson and Johnson is eager to expand. According to Reuters the company recently upped its offer for Actelion, a swiss biotech group, in hopes of buying out the smaller company...
Source: Wochit News -

News video: Jim Cramer Comments on J&J's Potential Deal With Actelion

Jim Cramer Comments on J&J's Potential Deal With Actelion 00:26

Jim Cramer is watching shares of Johnson & Johnson , as the company considers buying Swiss drugmaker Actelion, which specializes in blood pressure drugs. Reuters reported that J&J is raising its offer..
Source: The Street -

News video: J&amp;J &amp; Actelion: more mergers for big pharma?

J&amp;J &amp; Actelion: more mergers for big pharma? 01:22

U.S. healthcare giant Johnson &amp; Johnson is reported to be approaching Swiss biotechnology firm Actelion about a potential takeover. David Pollard reports.
Source: Rumble -

 

UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg

Dec 5 (Reuters) - Sanofi is considering a bid for Swiss biotech company Actelion, rivaling an offer made by U.S. healthcare company Johnson & Johnson, Bloomberg reported.
Reuters

Novartis CEO plays down prospects for Actelion bid: Blick

VIENNA (Reuters) - Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson..
Reuters

RPT-Actelion's silence has hedge funds betting big on J&J deal

ZURICH, Dec 2 (Reuters) - Actelion's silence speaks volumes to the dozens of event-driven hedge funds piling into the Swiss biotech firm, betting that Johnson & Johnson's (J&J) approach will result...
Reuters

Actelion’s Clozel aims to keep group’s independence

Biotech company chief’s science background comes into play in face of J&J bid
FT.com

Actelion shares fall on report it rejects J&J offer

ZURICH (Reuters) - Shares in Swiss biotech company Actelion fell more than 6 percent after news outlet streetinsider.com reported on Wednesday the company had rejected a full takeover offer by U.S...
Reuters

Rejecting J&J could leave Actelion with 'lot of explaining to do'

ZURICH/LONDON (Reuters) - Some Actelion shareholders would be attracted by a $27 billion bid for the Swiss biotech company from Johnson & Johnson, leaving Chief Executive Jean-Paul Clozel with some..
Reuters

Johnson & Johnson raising takeover offer for Actelion: source

LONDON (Reuters) - U.S. healthcare company Johnson & Johnson is raising its offer for Swiss biotech group Actelion in an attempt to win it over for a buyout, a source familiar with the situation said..
Reuters

BRIEF-Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources

* Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources
Reuters

Actelion shares jump after report J&J boosts takeover offer

ZURICH (Reuters) - Actelion shares rose more than 9 percent, rebounding from negative territory, after a Bloomberg News report on Tuesday that Johnson & Johnson had boosted its takeover offer for the..
Reuters

Actelion weighs complex deal with part of J&J

Structured transaction would see Swiss company remain independent
FT.com

You Might Like


 |<  Page 1  >> 
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2016 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+